Suchergebnisse - "Geretti, Anna Maria"

PubPharm (316)

31

Outcomes of COVID-19 related hospitalisation among people with HIV in the ISARIC WHO Clinical Characterisation Protocol UK Protocol: prospective observational study

enthalten in: bioRxiv.org | 2021

von Geretti, A. | Stockdale, A. | Kelly, S. | +19

32

Research news in clinical context

enthalten in: Sexually transmitted infections | 2020

von Ceccherini-Silberstein, F. | Fernández-Huerta, M. | Geretti, A.

33

Surveillance of HIV-1 transmitted integrase strand transfer inhibitor resistance in the UK

enthalten in: The Journal of antimicrobial chemotherapy | 2020

von Mbisa, J. | Ledesma, J. | Kirwan, P. | +8

34

Reply to : "Revisiting the estimation of hepatitis D global prevalence"

enthalten in: Journal of hepatology | 2020

von Stockdale, A. | Hutin, Y. | Geretti, A.

CommentOn: J Hepatol. 2020 Sep;73(3):523-532. - PMID 32335166

35

The global prevalence of hepatitis D virus infection : Systematic review and meta-analysis

enthalten in: Journal of hepatology | 2020

von Stockdale, A. | Kreuels, B. | Henrion, M. | +5

CommentIn: J Hepatol. 2020 Sep;73(3):493-495. - PMID 32684365

36

A phase IV randomised, open-label pilot study to evaluate switching from protease-inhibitor based regimen to Bictegravir/Emtricitabine/Tenofovir Alafenamide single tablet regimen in Integrase inhibitor-naïve, virologically suppressed HIV-1 infected adults harbouring drug resistance mutations (PIBIK study) : study protocol for a randomised trial

enthalten in: BMC infectious diseases | 2020

von Iwuji, C. | Churchill, D. | Bremner, S. | +7

37

A phase IV randomised, open-label pilot study to evaluate switching from protease-inhibitor based regimen to Bictegravir/Emtricitabine/Tenofovir Alafenamide single tablet regimen in Integrase inhibitor-naïve, virologically suppressed HIV-1 infected adults harbouring drug resistance mutations (PIBIK study): study protocol for a randomised trial

enthalten in: BMC infectious diseases | 2020

von Iwuji, C. | Churchill, D. | Bremner, S. | +7

38

A phase IV randomised, open-label pilot study to evaluate switching from protease-inhibitor based regimen to Bictegravir/Emtricitabine/Tenofovir Alafenamide single tablet regimen in Integrase inhibitor-naïve, virologically suppressed HIV-1 infected adults harbouring drug resistance mutations (PIBIK study): study protocol for a randomised trial

enthalten in: BMC infectious diseases | 2020

von Iwuji, C. | Churchill, D. | Bremner, S. | +7

39

HBV-RNA Co-amplification May Influence HBV DNA Viral Load Determination

enthalten in: Hepatology communications | 2020

von Maasoumy, B. | Geretti, A. | Frontzek, A. | +10

40

Continuation of emtricitabine/lamivudine within combination antiretroviral therapy following detection of the M184V/I HIV-1 resistance mutation

enthalten in: HIV medicine | 2020

von Stirrup, O. | Asboe, D. | Pozniak, A. | +107